Consultation needs in perinatal HIV care: experience of the National Perinatal HIV Consultation Service

American Journal of Obstetrics and Gynecology

Volumn 197, Issue 3 SUPPL., 2007, Pages

  Fogler, Jessica A ^a   Weber, Shannon ^a   Goldschmidt, Ronald H ^a   Mahoney, Megan R ^a   Cohan, Deborah ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

HIV testing; perinatal HIV care; pregnancy; telephone consultation

Indexed keywords

ANTIRETROVIRUS AGENT;

CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH PROMOTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; PERINATAL CARE; PREGNANCY; PRIORITY JOURNAL; REVIEW; TELECONSULTATION; UNITED STATES; VIRUS RESISTANCE;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HOTLINES; HUMANS; INFANT; LABOR, OBSTETRIC; NEEDS ASSESSMENT; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REFERRAL AND CONSULTATION;

EID: 34548358722     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2007.02.033     Document Type: Review

References (17)

1. Centers for Disease Control and Prevention (CDC). Achievements in public health. Reduction in perinatal transmission of HIV infection: United States, 1985-2005. MMWR Morb Mortal Wkly Rep 55 (2006) 592-597
2. Cooper E.R., Charurat M., Mofenson L., et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 29 (2002) 484-494
3. Naver L., Lindgren S., Belfrage E., et al. Children born to HIV-1-infected women in Sweden in 1982-2003: trends in epidemiology and vertical transmission. J Acquir Immune Defic Syndr 42 (2006) 484-489
4. Shapiro D., Tuomala R., Pollack H., et al. Mother-to-child HIV transmission risk according to antiretroviral therapy, mode of delivery, and viral load in 2895 US women (PACTG 367). [abstract] (2004) Presented at 11th Conference on Retroviruses and Opportunistic Infections
5. Branson B.M., Handsfield H.H., Lampe M.A., et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Morb Mortal Wkly Rep 55 (2006) 1-17
6. Chou R., Smits A.K., Huffman L.H., Fu R., and Korthuis P.T. Prenatal screening for HIV: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 143 (2005) 38-54
7. Gerberding J.L., and Jaffe H.W. "Dear colleague" letter (2003), National Center for HIV, STD and TB Prevention, Divisions of HIV/AIDS Prevention, Atlanta. http://www.cdc.gov/HIV/topics/perinatal/resources/other/dear_colleague-2003.htm Accessed April 22. Available at: http://www.cdc.gov/HIV/topics/perinatal/resources/other/dear_colleague-2003.htm
8. Fogler J.A., Weber S., Cohan D., and Goldschmidt R. Perinatal hotline: integrating distance-based clinical consultation, rapid testing, and patient referral. [abstract] (2006) Ryan White CARE Act All-Grantee Meeting, August 29, Washington, DC.
9. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (2006). http://aidsinfo.nih.gov/Guidelines October 12. Available at: http://aidsinfo.nih.gov/Guidelines. Accessed January 25, 2007.
10. Centers for Disease Control and Prevention (CDC). Advancing HIV prevention: new strategies for a changing epidemic: United States, 2003. MMWR Morb Mortal Wkly Rep 52 (2003) 329-332
11. Karchava M., Pulver W., Smith L., et al. Prevalence of drug-resistance mutations and non-subtype B strains among HIV-infected infants from New York State. J Acquir Immune Defic Syndr 42 (2006) 614-619
12. Novak R.M., Chen L., MacArthur R.D., et al. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy. Clin Infect Dis 40 (2005) 468-474
13. Moodley D., Moodley J., Coovadia H., et al. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 187 (2003) 725-735
14. Taha T.E., Kumwenda N.I., Gibbons A., et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet 362 (2003) 1171-1177
15. Wade N.A., Birkhead G.S., Warren B.L., et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 339 (1998) 1409-1414
16. Magee L.A., Murphy K.E., and von Dadelszen P. False-positive results in antenatal HIV screening. CMAJ 160 (1999) 1285
17. Ayala L., Garcia P., Statton A., and Cuden J. 24/7 Illinois perinatal HIV hotline: an essential part of perinatal HIV prevention (2006) Presented at the American Public Health Association Annual Meeting; November 4-8; Boston, MA.